Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria

Kathelyn S. Steimer, John P. Puma, Michael D. Power, Maureen A. Powers, Carlos George-Nascimento, James C. Stephans, Jay A. Levy, Ray Sanchez-Pescador, Paul A Luciw, Philip J. Barr, Robert A. Hallewell

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Infection with the retrovirus that is the etiological agent of acquired immune deficiency syndrome (AIDS) is characterized by the development of antiviral antibodies. To generate reagents for studying immune responses to individual viral proteins, we have produced viral antigens in microorganisms by recombinant DNA techniques. Large amounts of the major core protein (p25gag) of an isolate of the AIDS retrovirus (AIDS-associated retrovirus; ARV-2) have been directly expressed in Escherichia coli. Recombinant p25gag (R-p25gag) has been purified and used in an enzyme-linked immunosorbent assay (ELISA) for antibodies to p25gag. Serum samples obtained from 100 individuals with AIDS, AIDS-related complex (ARC), or potential exposure to the virus through sexual contact with AIDS or ARC patients (contacts) were tested first in an ELISA with disrupted whole virus to determine which of the subjects had mounted an antibody response to the virus (virus seropositive) and then in the p25gag ELISA to determine if they had antibodies to this particular viral antigen. We observed a decrease in the proportion of virus seropositive individuals with antibodies to p25gag among patient groups in which the disease was more advanced; contacts were often positive (71 % ),ARC patients less frequently positive (48%), and AIDS patients only rarely positive (16%). Our results suggest that monitoring p25gag seropositivity of infected individuals may be useful for predicting either the prognosis or the stage of the disease.

Original languageEnglish (US)
Pages (from-to)283-290
Number of pages8
JournalVirology
Volume150
Issue number1
DOIs
StatePublished - Apr 15 1986
Externally publishedYes

Fingerprint

Viral Antigens
Retroviridae
Antibody Formation
Acquired Immunodeficiency Syndrome
Bacteria
Viruses
AIDS-Related Complex
Antibodies
Enzyme-Linked Immunosorbent Assay
Retroviridae Infections
Viral Core Proteins
Recombinant DNA
Viral Proteins
Antiviral Agents
Escherichia coli
Serum

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Steimer, K. S., Puma, J. P., Power, M. D., Powers, M. A., George-Nascimento, C., Stephans, J. C., ... Hallewell, R. A. (1986). Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria. Virology, 150(1), 283-290. https://doi.org/10.1016/0042-6822(86)90289-8

Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria. / Steimer, Kathelyn S.; Puma, John P.; Power, Michael D.; Powers, Maureen A.; George-Nascimento, Carlos; Stephans, James C.; Levy, Jay A.; Sanchez-Pescador, Ray; Luciw, Paul A; Barr, Philip J.; Hallewell, Robert A.

In: Virology, Vol. 150, No. 1, 15.04.1986, p. 283-290.

Research output: Contribution to journalArticle

Steimer, KS, Puma, JP, Power, MD, Powers, MA, George-Nascimento, C, Stephans, JC, Levy, JA, Sanchez-Pescador, R, Luciw, PA, Barr, PJ & Hallewell, RA 1986, 'Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria', Virology, vol. 150, no. 1, pp. 283-290. https://doi.org/10.1016/0042-6822(86)90289-8
Steimer, Kathelyn S. ; Puma, John P. ; Power, Michael D. ; Powers, Maureen A. ; George-Nascimento, Carlos ; Stephans, James C. ; Levy, Jay A. ; Sanchez-Pescador, Ray ; Luciw, Paul A ; Barr, Philip J. ; Hallewell, Robert A. / Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria. In: Virology. 1986 ; Vol. 150, No. 1. pp. 283-290.
@article{63c5a40e70284b609417a70863ed97c2,
title = "Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria",
abstract = "Infection with the retrovirus that is the etiological agent of acquired immune deficiency syndrome (AIDS) is characterized by the development of antiviral antibodies. To generate reagents for studying immune responses to individual viral proteins, we have produced viral antigens in microorganisms by recombinant DNA techniques. Large amounts of the major core protein (p25gag) of an isolate of the AIDS retrovirus (AIDS-associated retrovirus; ARV-2) have been directly expressed in Escherichia coli. Recombinant p25gag (R-p25gag) has been purified and used in an enzyme-linked immunosorbent assay (ELISA) for antibodies to p25gag. Serum samples obtained from 100 individuals with AIDS, AIDS-related complex (ARC), or potential exposure to the virus through sexual contact with AIDS or ARC patients (contacts) were tested first in an ELISA with disrupted whole virus to determine which of the subjects had mounted an antibody response to the virus (virus seropositive) and then in the p25gag ELISA to determine if they had antibodies to this particular viral antigen. We observed a decrease in the proportion of virus seropositive individuals with antibodies to p25gag among patient groups in which the disease was more advanced; contacts were often positive (71 {\%} ),ARC patients less frequently positive (48{\%}), and AIDS patients only rarely positive (16{\%}). Our results suggest that monitoring p25gag seropositivity of infected individuals may be useful for predicting either the prognosis or the stage of the disease.",
author = "Steimer, {Kathelyn S.} and Puma, {John P.} and Power, {Michael D.} and Powers, {Maureen A.} and Carlos George-Nascimento and Stephans, {James C.} and Levy, {Jay A.} and Ray Sanchez-Pescador and Luciw, {Paul A} and Barr, {Philip J.} and Hallewell, {Robert A.}",
year = "1986",
month = "4",
day = "15",
doi = "10.1016/0042-6822(86)90289-8",
language = "English (US)",
volume = "150",
pages = "283--290",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria

AU - Steimer, Kathelyn S.

AU - Puma, John P.

AU - Power, Michael D.

AU - Powers, Maureen A.

AU - George-Nascimento, Carlos

AU - Stephans, James C.

AU - Levy, Jay A.

AU - Sanchez-Pescador, Ray

AU - Luciw, Paul A

AU - Barr, Philip J.

AU - Hallewell, Robert A.

PY - 1986/4/15

Y1 - 1986/4/15

N2 - Infection with the retrovirus that is the etiological agent of acquired immune deficiency syndrome (AIDS) is characterized by the development of antiviral antibodies. To generate reagents for studying immune responses to individual viral proteins, we have produced viral antigens in microorganisms by recombinant DNA techniques. Large amounts of the major core protein (p25gag) of an isolate of the AIDS retrovirus (AIDS-associated retrovirus; ARV-2) have been directly expressed in Escherichia coli. Recombinant p25gag (R-p25gag) has been purified and used in an enzyme-linked immunosorbent assay (ELISA) for antibodies to p25gag. Serum samples obtained from 100 individuals with AIDS, AIDS-related complex (ARC), or potential exposure to the virus through sexual contact with AIDS or ARC patients (contacts) were tested first in an ELISA with disrupted whole virus to determine which of the subjects had mounted an antibody response to the virus (virus seropositive) and then in the p25gag ELISA to determine if they had antibodies to this particular viral antigen. We observed a decrease in the proportion of virus seropositive individuals with antibodies to p25gag among patient groups in which the disease was more advanced; contacts were often positive (71 % ),ARC patients less frequently positive (48%), and AIDS patients only rarely positive (16%). Our results suggest that monitoring p25gag seropositivity of infected individuals may be useful for predicting either the prognosis or the stage of the disease.

AB - Infection with the retrovirus that is the etiological agent of acquired immune deficiency syndrome (AIDS) is characterized by the development of antiviral antibodies. To generate reagents for studying immune responses to individual viral proteins, we have produced viral antigens in microorganisms by recombinant DNA techniques. Large amounts of the major core protein (p25gag) of an isolate of the AIDS retrovirus (AIDS-associated retrovirus; ARV-2) have been directly expressed in Escherichia coli. Recombinant p25gag (R-p25gag) has been purified and used in an enzyme-linked immunosorbent assay (ELISA) for antibodies to p25gag. Serum samples obtained from 100 individuals with AIDS, AIDS-related complex (ARC), or potential exposure to the virus through sexual contact with AIDS or ARC patients (contacts) were tested first in an ELISA with disrupted whole virus to determine which of the subjects had mounted an antibody response to the virus (virus seropositive) and then in the p25gag ELISA to determine if they had antibodies to this particular viral antigen. We observed a decrease in the proportion of virus seropositive individuals with antibodies to p25gag among patient groups in which the disease was more advanced; contacts were often positive (71 % ),ARC patients less frequently positive (48%), and AIDS patients only rarely positive (16%). Our results suggest that monitoring p25gag seropositivity of infected individuals may be useful for predicting either the prognosis or the stage of the disease.

UR - http://www.scopus.com/inward/record.url?scp=0022632954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022632954&partnerID=8YFLogxK

U2 - 10.1016/0042-6822(86)90289-8

DO - 10.1016/0042-6822(86)90289-8

M3 - Article

C2 - 3006341

AN - SCOPUS:0022632954

VL - 150

SP - 283

EP - 290

JO - Virology

JF - Virology

SN - 0042-6822

IS - 1

ER -